Insmed INSM Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $606.42M+66.7% | $363.71M+19.2% | $305.21M+24.4% | $245.36M+30.2% | ||
| $122.94M+43.4% | $85.74M+30.8% | $65.57M+19.0% | $55.13M+24.9% | ||
| $771.09M+28.9% | $598.37M+4.8% | $571.01M+43.6% | $397.52M+45.7% | ||
| $701.17M+52.1% | $461.12M+33.9% | $344.5M+29.6% | $265.78M— | ||
| $1.85B+49.2% | $1.24B+22.4% | $1.01B+44.4% | $702.68M+24.7% | ||
| -$1.25B-42.0% | -$878.25M-23.8% | -$709.63M-55.2% | -$457.32M-21.9% | ||
| -205.6%+35.9pp | -241.5%-9.0pp | -232.5%-46.1pp | -186.4%+12.6pp | ||
| $83.8M-1.3% | $84.91M+3.9% | $81.69M+209% | $26.45M-34.7% | ||
| -$1.84M— | —— | $1.86M— | —— | ||
| -$1.27B-39.7% | -$910.07M-21.8% | -$747.01M-55.6% | -$480.15M-10.0% | ||
| $5.03M+35.6% | $3.71M+45.1% | $2.56M+84.7% | $1.38M+179% | ||
| -$1.28B-39.7% | -$913.77M-21.9% | -$749.57M-55.7% | -$481.53M-10.8% | ||
| -210.5%+40.7pp | -251.2%-5.6pp | -245.6%-49.3pp | -196.3%+34.4pp | ||
| -$6.40-14.9% | -$5.57-4.3% | -$5.34-36.2% | -$3.92-1.3% | ||
| -$1.23B-41.9% | -$867.24M-23.2% | -$704.13M-55.8% | -$452.02M-23.5% | ||
| -202.9%+35.6pp | -238.4%-7.7pp | -230.7%-46.5pp | -184.2%+10.0pp | ||
| -$1.25B-42.0% | -$878.25M-23.8% | -$709.63M-55.2% | -$457.32M-21.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Insmed's revenue?
- Insmed (INSM) generated $819.6M in revenue over the trailing twelve months, up 115.1% year over year.
- Is Insmed profitable?
- Insmed is not currently profitable: it reported a net loss of $1.2B over the trailing twelve months, a -144.4% net margin.
- What are Insmed's profit margins?
- Gross margin is 81.8% and operating margin is -140.6%, with a -144.4% net margin.
- What is Insmed's earnings per share?
- Insmed's diluted EPS over the trailing twelve months is $-5.74.
- Where does Insmed's income statement data come from?
- Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
